If you are on the fence about HOYA stock, you are definitely not alone. Watching a stock like this consistently deliver returns of 1.1% over the last week, 6.8% in the last month, and a solid 7.5% year to date makes plenty of investors itch to jump in. What is even more striking is HOYA’s long-term momentum, with the stock soaring 10.8% over the past year, 52.9% over the last three years, and an impressive 84.2% across five years. These numbers do not just happen by chance, and they speak to the company’s ability to navigate changing market environments and steadily grow shareholder value.

But we both know past performance only tells part of the story. Markets do not just reward growth; they reward value. So, when you see a company gaining the way HOYA has, it is no surprise to find whispers among investors debating whether it is now “too expensive” or still promising. Our valuation score for HOYA comes in at 1 out of 6 checks for being undervalued, which might raise some eyebrows if you are looking for a clear bargain.

So, how should you really view HOYA’s valuation? Over the next sections, we will dive into how each valuation method stacks up for HOYA, what that undervaluation score actually means, and just as importantly, explore an even more insightful way to think about the true worth of this company.

HOYA scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

The Discounted Cash Flow (DCF) model estimates a company’s fair value by projecting its future cash flows and discounting them back to today at an appropriate rate. This approach helps investors understand what HOYA could potentially be worth if its future performance matches these projections.

Currently, HOYA’s Free Cash Flow stands at approximately ¥195.9 billion. Looking ahead, analyst projections suggest free cash flow could grow to around ¥297.4 billion by 2030. The estimates for the next five years are based on analyst inputs, while growth beyond that draws from Simply Wall St’s extrapolations, reflecting more modest growth rates as the timeline extends further out.

Based on this DCF model, HOYA’s estimated intrinsic value comes to ¥18,466 per share. Compared to the recent market price, this implies the stock is about 14.1% overvalued at current levels.

In summary, while HOYA shows strong, consistent cash flow growth, the DCF assessment signals a valuation that is running ahead of those fundamentals right now.

Result: OVERVALUED

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for HOYA.

Our Discounted Cash Flow (DCF) analysis suggests HOYA may be overvalued by 14.1%. Find undervalued stocks or create your own screener to find better value opportunities.

The Price-to-Earnings (PE) ratio is the go-to valuation metric for profitable companies like HOYA because it directly compares a company's market price to its earnings, providing a straightforward snapshot of how much investors are willing to pay for every ¥1 of profits. When a company is consistently profitable, the PE ratio can reveal how the market is pricing its growth prospects and risks relative to those of other firms.

It is important to remember that a “fair” PE ratio is not one-size-fits-all. Higher growth expectations typically warrant a higher multiple, as do lower perceived risks, while companies facing uncertainty or slow growth usually see a lower PE. With that in mind, HOYA’s current PE ratio stands at 34.9x, a level well above the broader Medical Equipment industry average of 16.4x. However, compared to its peer group, which averages a remarkable 53.9x, HOYA’s figure seems more moderate.

Simply Wall St’s “Fair Ratio” model provides a more contextual benchmark by factoring in HOYA’s specific strengths such as profit margins, future growth outlook, size, and industry profile. For HOYA, the Fair PE Ratio is calculated at 33.7x, reflecting these underlying fundamentals rather than just making blanket comparisons to peers or sector averages. This tailored approach allows investors to gauge whether the current price reflects HOYA’s real earnings potential and risk profile.

With HOYA trading at 34.9x and its Fair Ratio at 33.7x, the valuation is just slightly above the mark. The difference is small enough to suggest that HOYA is trading at levels that are well-aligned with its true value, given its growth and profitability.

Result: ABOUT RIGHT

PE ratios tell one story, but what if the real opportunity lies elsewhere? Discover companies where insiders are betting big on explosive growth.

Earlier, we mentioned there is an even better way to understand a company’s value through Narratives. A Narrative is simply your story about HOYA’s future, where you describe what you believe the company can achieve and why. You then link that story to your financial forecast, such as future revenue, earnings, and profit margins, and a Fair Value estimate. Narratives connect the numbers to the bigger picture, making it easy to see not just what the company has done, but where it is headed and why. On Simply Wall St’s Community page, which is used by millions of investors, it is simple to create or explore Narratives tailored to your own perspective. These unique stories help you decide if it is time to buy or sell by comparing your calculated Fair Value to the current market Price, and they automatically update as new news or earnings reports come in. For example, one HOYA investor might create a Narrative with a very optimistic Fair Value, while another has a more cautious outlook based on lower growth assumptions. Narratives empower you to invest with intent, turning your perspective into actionable intelligence tailored just for you.

Do you think there's more to the story for HOYA? Create your own Narrative to let the Community know!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include 7741.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com